2 exciting ETFs named as buys by experts

Here are two ETFs that could be buys…

| More on:
A young woman sits with her hand to her chin staring off to the side thinking about her investments.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're wanting to buy some exchange traded funds (ETFs), then you certainly have a lot of options.

But which ones could be buys? Two that have been tipped as buys by analysts are listed below. Here's what they are saying about them:

ETFS Battery Tech & Lithium ETF (ASX: ACDC)

If you're wanting to get some exposure to the decarbonisation megatrend, then the ETFS Battery Tech & Lithium ETF could be one way to do it.

This popular ETF allows investors to buy a slice of companies involved in battery technology, electric vehicles, and lithium mining. This includes BYD, Mineral Resources Limited (ASX: MIN), Pilbara Minerals Ltd (ASX: PLS), Nissan, and Renault.

Jessica Amir from Saxo Markets is positive on the ETF. Especially for investors that aren't keen on stock picking in the lithium sector. She commented:

If stock picking is not for you, and if you believe, like we do, that the electric vehicle industry and the critical minerals/ commodities will continue to see rising demand, and policy support, and also benefit from the world striving to be carbon neutral by 2050, then you could invest or trade in Global X Lithium & Battery Tech ETF (LIT) or ETFS Battery Tech & Lithium ETF (ACDC) that invests in about 30 of the biggest EV and battery technology companies in the world.

ETFS S&P Biotech ETF (ASX: CURE)

Another ETF that has been tipped as a buy is the ETFS S&P Biotech ETF. As its name implies, this ETF gives investors access to U.S. healthcare biotechnology companies.

The fund manager notes that these companies are engaged in the research, development and manufacturing of products based on genetic analysis and genetic engineering. This includes the development of immunotherapy treatments and vaccines to treat human diseases.

Among its largest holdings are ChemoCentryx, Global Blood Therapeutics, and Twist Bioscience.

Felicity Thomas from Shaw & Partners is a fan of the ETF. She recently told Livewire:

I like to buy ETFs for the long term. We have an ageing population, and what's the most important thing in the world? Your health. Biotech, healthcare, and life sciences, that's where you want to be invested over the next couple of decades.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ETFs

A smiling woman sits in a cafe reading a story on her phone about Rio Tinto and drinking a coffee with a laptop open in front of her.
ETFs

5 ASX ETFs for beginner investors in 2026 and beyond

Starting your investment journey? Here's an easy way to start.

Read more »

A trendy woman wearing sunglasses splashes cash notes from her hands.
ETFs

Could this undervalued ASX stock be your ticket to millionaire status?

This investment could deliver almost everything an investor could want to reach $1 million.

Read more »

Young Female investor gazes out window at cityscape
ETFs

3 high-quality ASX ETFs to buy in December

Want to invest in the best stocks? Here's an easy way to do it.

Read more »

Two men look excited on the trading floor as they hold telephones to their ears and one points upwards.
ETFs

3 explosive ASX ETFs to buy and hold

These funds could be destined for big things in the future. Let's find out why.

Read more »

Miner with thumbs up at mine
ETFs

Expert names 2 preferred ASX ETFs reaping the rewards of surging mining shares

Mining-focused ASX ETFs have been boosted by rising commodity prices and higher mining share prices in 2025.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
ETFs

This new ETF aims to pay high monthly dividends, helped along by gearing

A new ETF from Betashares aims to deliver a strong monthly dividend yield without excess volatility.

Read more »

A man points at a paper as he holds an alarm clock, indicating the ex-dividend date is approaching.
ETFs

3 ASX ETFs I'd buy right now to build wealth

Here's why these funds could be destined to deliver big returns over the next decade.

Read more »

Three happy construction workers on an infrastructure site have a chat.
ETFs

Meet the newest ASX ETF from Betashares

Meet the new kid on the block.

Read more »